Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.1.1.7 (acetylcholinesterase)
 28,390 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Choline acetyltransferase (ChAT), the biosynthetic enzyme for acetylcholine metabolism, is expressed in a human cholinergic neuroblastoma cell line; MC-IXC. We demonstrate that ChAT activity is regulated in this cell line by cell density. It is believed that the mechanism of stimulation of enzyme activity involves cellular contact, as medium conditioned by cells of high density failed to mimic the effect of density alone, and trypsinization reversed this effect. Density did not increase acetylcholinesterase activity, another marker for the cholinergic phenotype, in MC-IXC cultures, demonstrating the independent regulation of these two cholinergic enzymes. Since increased density slows the rate of cell division, we used a DNA synthesis inhibitor to uncouple DNA replication from cell density. This had no effect on the specific activity of ChAT, suggesting that a cell-cell contact was the mediating factor. Other neuroblastoma cell lines were tested, and only cell lines which already contain ChAT activity were sensitive to its regulation by cell-cell contact, suggesting that cell-cell contact is permissive rather than instructive in this process. The effect of cell passage on ChAT activity is also discussed.
 ...
PMID:Regulation of choline acetyltransferase activity by cell density in a cultured human neuroblastoma cell line. 246 20

Choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) were measured in anterior and posterior grey matter of the lumbar spinal cord and in temporal and frontal cortex from six cases of Alzheimer-type dementia (ATD), one case of Down's syndrome, three cases of schizophrenia (SZ) and six controls. Compared with control and SZ values, ChAT and AChE were reduced in ATD cerebral cortex. ChAT was reduced, and AChE unaltered, in ATD spinal cord. Decreased cord ChAT may be related to electrophysiological abnormalities which have been reported in motor nerves of patients with Alzheimer's disease.
 ...
PMID:Cholinergic enzymes in the spinal cord in Alzheimer-type dementia. 253 18

Choline acetyltransferase immunohistochemistry showed that the human rostral brainstem contained cholinergic neurons in the oculomotor, trochlear, and parabigeminal nuclei as well as within the reticular formation. The cholinergic neurons of the reticular formation were the most numerous and formed two intersecting constellations. One of these, designated Ch5, reached its peak density within the compact pedunculopontine nucleus but also extended into the regions through which the superior cerebellar peduncle and central tegmental tract course. The second constellation, designated Ch6, was centered around the laterodorsal tegmental nucleus and spread into the central gray and medial longitudinal fasciculus. There was considerable transmitter-related heterogeneity within the regions containing Ch5 and Ch6. In particular, Ch6 neurons were intermingled with catecholaminergic neurons belonging to the locus coeruleus complex. The lack of confinement within specifiable cytoarchitectonic boundaries and the transmitter heterogeneity justified the transmitter-specific Ch5 and Ch6 nomenclature for these two groups of cholinergic neurons. The cholinergic neurons in the nucleus basalis (Ch4) and those of the Ch5-Ch6 complex were both characterized by perikaryal heteromorphism and isodendritic arborizations. In addition to choline acetyltransferase, the cell bodies in both complexes also had high levels of acetylcholinesterase activity and nonphosphorylated neurofilament protein. However, there were also marked differences in cytochemical signature. For example, the Ch5-Ch6 neurons had high levels of NADPHd activity, whereas Ch4 neurons did not. On the other hand, the Ch4 neurons had high levels of NGF receptor protein, whereas those of Ch5-Ch6 did not. On the basis of animal experiments, it can be assumed that the Ch5 and Ch6 neurons provide the major cholinergic innervation of the human thalamus and that they participate in the neural circuitry of the reticular activating, limbic, and perhaps also extrapyramidal systems.
 ...
PMID:Human reticular formation: cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. 254 47

The present study investigated differences in cholinergic function which might contribute to genetic differences in the effects of ethanol on inbred mice. Choline acetyltransferase (ChAT), acetylcholinesterase (AChE) activity and [3H]-quinuclidinyl benzilate (QNB) binding were assessed in several brain areas after administration of ethanol (4.6 g/Kg). ChAT in striatum and septum of C57BL/6 mouse strain exhibit greater sensitivity to ethanol as compared to BALB/c mouse strain. While BALB/c limbic system and related structures showed greater sensitivity to ethanol as compared to C57BL/6 strain. Our previous studies indicated that acute ethanol administration in C57BL/6 mice increased striatal ChAT activity (up to 22% with 60 min latency, Durkin et al., 1982). This augmentation in ChAT activity induced by ethanol was associated with non-synchronous decreases in kinetic characteristics of QNB binding in striatum. In contrast, no such changes were seen in BALB/c striatum (except we noted an increase in Kd up to 90 min after acute ethanol treatment). Similar significant increases in ChAT activity were also observed in C57BL/6 septum 165 min after ethanol administration. However, the septum in BALB/c mice did not exhibit comparable changes. Ethanol did increase ChAT activity in several brain areas of both strains. The areas included the hippocampus, temporal limbic cortex and piriform cortex or paleocortex. Interestingly, the latencies to increased ChAT activity in these areas were much shorter in BALB/c than in C57 mice. The kinetic characteristics of QNB binding sites (Bmax and Kd) and AChE activity were unchanged in all brain areas and did not differ by strain except as otherwise indicated. These data indicate that genetic differences in ethanol preference and sensitivity in these strains are accompanied by differential sensitivity of ChAT to acute ethanol. Genotypic variations in dopaminergiccholinergic interactions in striatum and hippocampus (Durkin et al., 1983), and septum (Kempf et al., 1985), temporal limbic and piriform cortex, could contribute to genetic differences in cholinergic sensitivity to ethanol. In addition, different blood-brain barrier and membrane properties might also contribute to genetic differences in the sensitivity of cholinergic function to ethanol. The differential effects on ChAT activity might participate in genetic differences in memory disorders (limbic system and related structures) and motor incoordination (basal ganglia) following high dose alcohol administration.
 ...
PMID:Genetically-determined responses of central cholinergic markers: the effects of ethanol on inbred strains of mice. 262 17

Choline acetyltransferase (ChAT) activity, the sedimentation and solubility forms of acetylcholinesterase (AChE) as well as total (3H-quinuclidinyl benzilate, QNB) and M1 (3H-pirenzepine, PZ) muscarinic binding were investigated in the temporal cortex (TC) and nucleus caudatus (NC) of both non-demented and demented parkinsonian patients and controls. ChAT activity and low-salt-soluble and detergent-soluble AChE were lower in the TC of demented patients with Parkinson's disease than in controls. ChAT activity and the solubility forms of AChE in the NC did not differ between controls and parkinsonian patients. In the TC, the activity of the intermediate form of AChE was lower in parkinsonian patients, but the activity of the light form of AChE did not differ between controls and parkinsonian patients. In the TC of patients with Parkinson's disease the Bmax of 3H-QNB binding was slightly higher than in controls, but the Bmax of 3H-PZ binding did not differ between controls and parkinsonian patients. In the NC the Bmax of 3H-QNB binding was unchanged compared to that of the controls. The concomitant decrease of ChAT with soluble as well as membrane-bound tetrameric AChE suggests a close relationship between ChAT and tetrameric form of AChE. M1 receptors (3H-PZ binding sites) are not affected in the TC, but are decreased in the NC of demented parkinsonian patients. This decrease may be secondary to the loss of dopaminergic neurons projecting from the substantia nigra to the striatum.
 ...
PMID:Different forms of brain acetylcholinesterase and muscarinic binding in Parkinson's disease. 272 71

In this study the distribution of the cholinergic neurons was examined in relation to the compartmental organization of nucleus accumbens. This was accomplished by charting the location of the choline acetyltransferase-immunoreactive neurons and mapping their distribution in relation to cytoarchitectural features and the patterns of acetylcholinesterase activity and enkephalin immunoreactivity. Choline acetyltransferase-containing perikarya are inhomogeneously distributed in nucleus accumbens. Their density is lowest at the rostral pole and highest, caudomedially, at the septal pole. The cells form a compact, medial column and a diffuse, lateral zone and, moreover, there are distinct gradients in their distribution. The highest numbers of immunoreactive perikarya occur within the intensely immunostained zones of choline acetyltransferase-immunoreactive neuropil in ventral and ventromedial parts of the nucleus, whereas lower numbers coincide with choline acetyltransferase-poor zones in the central part of the nucleus. Zones of intensely choline acetyltransferase-immunoreactive neuropil are largely in register with regions of high acetylcholinesterase activity in middle and caudal parts of the nucleus but do not coincide rostrally. Choline acetyltransferase-rich zones correspond to moderate enkephalin immunoreactivity in the outer shell of the nucleus, but a moderately choline acetyltransferase-immunostained matrix surrounds "patches" of intense enkephalin immunoreactivity in the core. Small aggregates of cells, which feature commonly in nucleus accumbens, seem to be avoided by both choline acetyltransferase- and enkephalin-immunoreactive zones. Choline acetyltransferase-immunoreactive processes are mostly confined by the boundaries of their respective immunoreactive zones. Few choline acetyltransferase-immunoreactive neurons lie in the enkephalin-rich patches and those that lie close to the patches show little preference in the directionality of their processes such that some cross the borders, whereas others do not. Thus, our findings show that the cholinergic elements are differentially distributed within nucleus accumbens; that these elements are compartmentally ordered; and that, in light of their limited access to other compartments, they possibly play only a minor role in intercompartmental communication.
 ...
PMID:The distribution and compartmental organization of the cholinergic neurons in nucleus accumbens of the rat. 279 39

Biochemical parameters were determined in autopsy material from several brain regions of thirteen patients with Alzheimer's disease/senile dementia of Alzheimer type (AD/SDAT) (mean age 75 years) and from brains of ten age-matched controls (mean age 76 years). Choline acetyltransferase specific activity was significantly lower in the nucleus caudatus, putamen, left thalamus, hippocampus and the cortex from gyrus hippocampus and the temporal lobe in AD/SDAT, acetylcholinesterase specific activity was significantly lower in the hippocampus, parietal and left frontal lobe in AD/SDAT samples than in corresponding samples from aged-matched controls. A compensatory increase of muscarinic receptors was found in the nucleus caudatus and left frontal lobe samples in AD/SDAT. Guanylate cyclase activity was not significantly altered in AD/SDAT in the brain regions examined. The basal, non-stimulated activity of adenylate cyclase was significantly (p less than 0.05) elevated in hippocampus samples from AD/SDAT patients and the enzyme activity stimulated by the vasoactive intestinal polypeptide VIP (2 microM) or forskolin (10 microM) was also elevated in AD/SDAT although not significantly.
 ...
PMID:VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type. 289 39

1. The choline acetyltransferase and acetylcholinesterase activities in the cerebral cortex and hippocampus and muscarinic binding in the cerebral cortex did not differ significantly between male and female Wistar rats. 2. Choline acetyltransferase activities in the cerebral cortex and hippocampus of rats were not altered during ageing. 3. Acetylcholinesterase activities in these same brain areas were markedly decreased during ageing, possibly reflecting a loss of postsynaptic enzyme activity. 4. When measured using 3H-pirenzepine, binding to the postsynaptic muscarinic receptors was slightly higher in 26-month-old rats than in 12-month-old rats; total muscarinic binding measured using 3H-quinuclidinyl benzilate did not alter during ageing. 5. The present study does not support the hypothesis that in the rat brain the number of postsynaptic muscarinic binding sites decreases during ageing.
 ...
PMID:Cholinergic enzyme activities and muscarinic binding in the cerebral cortex of rats of different age and sex. 290 66

Choline acetyltransferase (Acetyl-CoA:choline O-acetyltransferase, EC 2.3.1.6, abbreviated ChAT), the biosynthetic enzyme for acetylcholine and acetylcholinesterase (EC 3.1.1.7, abbreviated AChE) are expressed in a human cholinergic neuroblastoma cell line, MC-IXC. We have shown that ChAT activity can be regulated in culture by retinoic acid, an active metabolite of vitamin A, and by sodium butyrate, an organic fatty acid. Optimal concentrations of these agents produce 4.3-fold and 1.6-fold increases in ChAT activity, respectively. The effects of retinoic acid are statistically significant after 24 h, whereas for sodium butyrate significant differences are seen only after 48 h. Since retinoic acid stimulation of ChAT activity was reversed only by trypsin treatment and not by removal of retinoic acid from the medium, this suggests that this agent may be acting at the level of the cell surface. Other differentiating conditions, such as culture in serum-free medium or addition of 1-2% dimethylsulfoxide did not increase ChAT activity. Acetylcholinesterase activity was shown to increase only in the presence of sodium butyrate, suggesting that retinoic acid and sodium butyrate may be acting via different pathways. Retinoic acid and sodium butyrate both seem to be permissive rather than instructive in regulating ChAT activity in that they are unable to induce ChAT expression de novo in cell lines which do not already express ChAT activity.
 ...
PMID:Stimulation of choline acetyltransferase activity by retinoic acid and sodium butyrate in a cultured human neuroblastoma. 292 23

Choline acetyltransferase (ChAT) activity in the cerebral cortex and the different solubility fractions of acetylcholinesterase (AChE) in the cerebral cortex and cerebellum were investigated in rats of different ages. ChAT activity was not decreased markedly in the cerebral cortex of 24- to 25-month-old rats compared to 3- to 4-month-old rats. The activity of detergent-soluble (DS) AChE in the cerebral cortex and cerebellum was lower in the older rats (24-25 months) rats than in younger (3-4 months) ones. The activity of DS-AChE in the cerebral cortex and cerebellum did not differ between 10- to 11-month-old and 24- to 25-month-old rats. The activity of low salt soluble (LSS) AChE in the cerebral cortex and cerebellum did not differ between older and younger rats.
 ...
PMID:Age-dependence of the solubility fractions of acetylcholinesterase in the cerebral cortex and cerebellum of the rat. 292 24


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>